The global oligonucleotide synthesis market is experiencing explosive growth, projected to surge from $8.8 billion in 2024 to a staggering $19.7 billion by 2029 at a compound annual growth r… Read More
The global oligonucleotide synthesis market is booming, projected to grow from $8.8 billion in 2024 to a staggering $19.7 billion by 2029 at a compound annual growth rate (CAGR) of 17.5%. Th… Read More
Amy Del Medico: Hi everyone, I’m Amy del Medico and I’m here today with Josh Mandel-Brehm from CAMP4 Therapeutics. Josh, welcome, would you like to give a little introduction on… Read More
According to a new report by MarketsandMarkets – Oligonucleotide Synthesis Market in terms of revenue was estimated to be worth $8.8 billion in 2024 and is poised to reach $1… Read More
The target spectrum and treatable diseases of small nucleic acid drugs are diverse. Relevant companies primarily focus on rare monogenic diseases with clear pathogenic mechanisms, well-defin… Read More
Protein homeostasis refers to the balance of proteins within cells, involving processes such as protein synthesis, folding, modification, transport, function, and degradation. Proteins in ce… Read More
Amylyx Pharmaceuticals announced yesterday that it will be pulling its ALS (amyotrophic lateral sclerosis) drug Relyvrio from the market after failing in a confirmatory trial.
In a statement… Read More
In the early 1980s, offices were noisy places, filled with the sound of metal striking inked ribbons to mark characters on paper. IBM Selectric typewriters clacked, daisy wheel printers cla… Read More
In the early 21st century, after the completion of the Human Genome Project, it was discovered that many diseases were caused by gene mutations leading to insufficient expression of function… Read More
You might have seen the name on a listing of NIH institutes and centers: the National Center for Advancing Translational Sciences (NCATS). “What the heck are they up to?” you m… Read More
Aptamers are short RNA/DNA oligonucleotide molecules that bind specifically to complementary target molecules. As potential recognition elements, aptamers show promising applicatio… Read More
What Causes Calcium Deposits In Heart Valves – Calcific aortic valve disease (CAVD) is the most common heart valve disease and its incidence is expected to increase as the population a… Read More
RNA Therapeutics Market in terms of revenue was estimated to be worth $13.7 billion in 2023 and is poised to reach $18.0 billion by 2028, growing at a CAGR of 5.6% from 2023 to 2028 accordin… Read More
Biogen will discontinue its controversial Alzheimer’s disease drug aducanumab (Aduhelm), the company announced Wednesday.
The drugmaker will stop developing and selling aducanumab, a… Read More
Genetically engineered drugs are introduced into host cells such as Escherichia coli, yeast or mammalian cells through recombinant technology to construct engineering strains or cell strains… Read More
In recent years, small nucleic acid drugs have emerged as a focal point in biomedical research due to their strong specificity, simple design, short development cycles, and diverse target op… Read More
RNA-based therapeutics
The Human Genome Project (HGP) has revealed a wealth of information about the human genome and has greatly enhanced its role in the development of biomedical resear… Read More
Introduction of Oligonucleotides
Oligonucleotide-based therapeutics represent a rapidly advancing field in current drug development. According to their therapeutic mechanisms, oligon… Read More
DelveInsight’s, “Pyelonephritis Pipeline Insight, 2023” report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in the Pyelonephritis pipeline land… Read More
Designing new drugs can be a tedious and laborious process. The result has been that relatively few effective new drugs have been clinically implemented in the past several decades. Utilizin… Read More
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Sepsis pipeline constitutes 40+ key companies continuously working towards developing 40+ Sepsis treatm… Read More
As an important drug modality, the development of oligonucleotides will continue to expand in the coming years. Oligonucleotide drugs are a class of therapeutic agents composed of short nucl… Read More
DNA Microarray Market Outlook
According to a new report by Expert Market Research titled, “Global DNA Microarray Market Size, Share, Analysis, Report and Forecast 2024-2032, the … Read More
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Persistent Corneal Epithelial Defects pipeline constitutes 5+ key companies continuously working toward… Read More
Nucleic acid drugs are mainly divided into two major categories: small nucleic acid drugs and mRNA. Small nucleic acid drugs, also known as oligonucleotide drugs, include antisense nucleotid… Read More
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Non-Alcoholic Steatohepatitis pipeline constitutes 100+ key companies continuously working towards deve… Read More
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Hemophilia pipeline constitutes 80+ key companies continuously working towards developing 80+ Hemophili… Read More
The length of siRNA is 7-8 nm, the diameter is 2-3 nm, the molecular weight is 13-14 kDa, and it is hydrophilic. Therefore, unmodified and naked siRNA cannot passively cross the cell membran… Read More
The concept of drug conjugates originated in the early 20th century. In 1910, Paul Ehrlich proposed the “Magic Bullet” theory, which aimed to describe the concept of a drug that… Read More
Delveinsight Business Research LLP
As per DelveInsight’s assessment, globally, about 75+ key pharma and biotech companies are working on 80+ pipeline drugs in the Wet Age-Related Mac… Read More
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Esophageal Cancer pipeline constitutes 80+ key companies continuously working towards developing 80+ Es… Read More
Novaliq, a biopharmaceutical company specializing in ocular therapeutics, recently announced that their product Vevye (cyclosporine ophthalmic solution) 0.1 percent received approval from th… Read More
Metabolic syndrome refers to a class of complex metabolic disorders, including adipose tissue accumulation, insulin resistance, diabetes, hyperinsulinemia, hypertension, and dyslipidemia, ch… Read More
Last week, the US Food and Drug Administration (FDA) granted accelerated approval to Biogen’s Qalsody (tofersen) for the treatment of adult patients with amyotrophic lateral sclerosis… Read More
The FDA granted accelerated approval to tofersen (Qalsody) for amyotrophic lateral sclerosis (ALS) patients with mutations in the SOD1 gene, the agency announced on Tuesday.
The drug was c… Read More
Bharat Book Bureau Provides the Trending Market Research Report on “Global Oligonucleotide Synthesis Market 2022-2028”under Life Science Market Research Report Category. Th… Read More
International Women’s Day gives us all a chance to reflect on and celebrate the progress women have made in historically male-dominated fields, such as science, technology, engineering… Read More
The Global Oligonucleotide Synthesis Market was valued at USD 6.3 billion in 2021 and is expected to register a CAGR of 17.6% during the forecast period (2022 – 2026). The report studi… Read More